Solute Carrier Family 12 (nonspecified subtype) Related Diseases

Solute Carrier Family 12 (nonspecified subtype)

Related Diseases

1) Dent Disease
Dent Disease 1, also known as dent disease, is related to hypophosphatemic rickets, x-linked recessive and rickets, and has symptoms including bone pain An important gene associated with Dent Disease 1 is CLCN5 (Chloride Voltage-Gated Channel 5), and among its related pathways/superpathways are Activation of cAMP-Dependent PKA and Transport of inorganic cations/anions and amino acids/oligopeptides. The drugs Hydrochlorothiazide and Antihypertensive Agents have been mentioned in the context of this disorder. Affiliated tissues include kidney, bone and cortex, and related phenotypes are aminoaciduria and hematuria

2) Bartter Syndrome
Bartter Disease, also known as bartter syndrome, is related to bartter syndrome, type 5, antenatal, transient and bartter syndrome, type 4b, neonatal, with sensorineural deafness. An important gene associated with Bartter Disease is BSND (Barttin CLCNK Type Accessory Subunit Beta), and among its related pathways/superpathways are Transport of inorganic cations/anions and amino acids/oligopeptides and Neuropathic Pain-Signaling in Dorsal Horn Neurons. The drugs Acetazolamide and Parathyroid hormone have been mentioned in the context of this disorder. Affiliated tissues include Kidney, adrenal cortex and cortex, and related phenotypes are short stature and abnormality of metabolism/homeostasis

The "Solute Carrier Family 12 (nonspecified subtype) Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about Solute Carrier Family 12 (nonspecified subtype) comprehensively including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

Disease Target / Biomarker

<< Back